The PharmaTell Team has had Eyes On — The Pharma CI Europe Conference, US FDA Regulatory Updates. Plus we are keeping eyes out for key Clinical Data Readouts in 2H22.
Eyes On Pharma CI
Janno went to the Pharma CI Europe Conference & Exhibition. There he was excited to catch-up with customers both new and old, and to meet all the different attendees that are working in the Healthcare CI sector. He learned about how clients are using PharmaTell’s Strategic Healthcare Intel for their Competitive Intel activities and in even more areas of their companies. As you can imagine, he came back to the office with many new ideas for improving and expanding PharmaTell’s Cloud-based platform. We’ll keep you in the loop as we explore and test some of the new innovations to make PharmaTell Studio even better for your Strategic Planning activities.
Eyes on Regulatory Updates
June was a busy month for the FDA – with many different panels meeting to discuss data on potential new products. Bluebird, Moderna, Pfizer/BioNTech, and Novavax were all recipients of positive recommendations from their respective panels. While Alnylam’s Amvuttra (amyloidosis polyneuropathy) and Merck’s Vaxneuvance (pneumococcal vaccine for infants) both received FDA Approvals. More details on all the FDA activities in June can be found in Studio.
Eyes On Upcoming Clinical Data Readouts
The second half of 2022 is set up to be busy with many firms expecting to release Clinical Data. The BioPharmaDive team have published a Deep Dive on some of the key trials to watch over the next few months. The trials from a mix of large and small BioTechs include Alzheimer’s Disease, Cardiomyopathy, PAH, Cancer, Lymphoma, and Geographic Atrophy. Read the details here from BioPharmaDive.
Tip of the Week
This week’s tip is a reminder to our new(ish) users that help is easily accessible on the PharmaTell Studio Dashboard. We have included an Introduction Video that provides an overview of all the functionality available in Studio. We also have a Presentation with screen shots and mark-ups to walk you through some of the search options. And as always – please send a note to the Helpdesk with any other questions you may have.
If you haven’t activated your PharmaTell Studio account or can’t access the links or if you are interested in a free trial of PharmaTell, please send us an email to firstname.lastname@example.org and we will be happy to assist you.
What were you keeping your eyes on this week? Feel free to comment or drop us a note on the Pharma Intel you are tracking. ‘Til next time – Robin